Fortress Biotech Reports Financial Results for the Third Quarter 2015 Ended September 30, 2015 Nov 09, 2015
Checkpoint Therapeutics Announces Appointment of James F. Oliviero, III, as President & Chief Executive Officer Oct 16, 2015
Fortress Biotech Reports Financial Results for the Second Quarter 2015 Ended June 30, 2015 Aug 10, 2015
Fortress Biotech Subsidiary, Altamira Bio, Acquires NIH License and CRADAs Relating to the Development of N-acetyl-D-mannosamine (ManNAc) for Rare Genetic Disorders Jul 17, 2015
Fortress Biotech Reports Financial Results for the First Quarter 2015 Ended March 31, 2015 May 11, 2015
